SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Stock Swap
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeffrey S. Mitchell who wrote (14473)6/17/1998 10:13:00 AM
From: Tech Master  Read Replies (2) of 17305
 
Jeff-

CELN's approach with Duke is very a novel approach for delivery of compounds to tumor sites. The stock has no real following yet.... yet. <ggg>

Other cancer companies may team with CELN to use the delivery systems... definitely big news for CELN.

Tech Master

P.S. Too bad you missed Night Line last night.... nice piece on cancer therapies.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News